Labshake search
Citations for R&D Systems :
701 - 750 of 2557 citations for Recombinant Human ABHD15 His tagged since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... 0.1% v/v FBS with or without 100 ng/ml Cyr61 (Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN). Medium change was performed at day 3 and images were taken at 3 and 5 days using a Keyence BZ-X800 Fluorescence Microscope (Keyence ...
-
bioRxiv - Bioengineering 2024Quote: A total of 1 μg Cyr61 (Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN) was dissolved in GelMA/fibrin hydrogel containing thrombin and transferred into a cylinder-shaped mold with a liquid capacity of 8.6 μl and 1 mm diameter with 1 mm thickness ...
-
bioRxiv - Bioengineering 2024Quote: Dye-labeled antimicrobial therapeutics (VHHα-(ABD)2-(EEG)6-Sx-POL-Cy7 or VHH16-ABD-(EEG)6-S17-PNT4-sulfo-Cy7) were incubated with recombinant human ADAM10 (R&D Systems, MN, U.S.A.) at 10 μM and 250 nM final concentrations respectively ...
-
bioRxiv - Bioengineering 2024Quote: ... foregut cells in the 24-well plate or on the pillar plate were cultured in advanced DMEM/F12 supplemented with 5 ng/mL recombinant human FGF basic/FGF2/bFGF (R&D systems; 233-FB), 10 ng/mL recombinant human VEGF-165 (Gibco ...
-
bioRxiv - Cell Biology 2024Quote: ... Naïve T-cells were incubated in complete medium supplemented with 10 IU/mL recombinant human IL-2 (R&D Systems, 202-IL-050/CF). As a positive control ...
-
bioRxiv - Cancer Biology 2023Quote: ... Experiments investigating EV-free AREG were undertaken by incubating recipient cells with 0.03 – 3000 ng/ml recombinant human Amphiregulin protein (R&D Systems #262-AR-100), for 30 minutes at 37°C before plating as described above.
-
bioRxiv - Molecular Biology 2023Quote: ... cells were maintained in serum-starved media with or without 10ng/ml of recombinant human TGF-β1 (R&D Systems, cat 240-B/CF) for 48 hours and harvested ...
-
bioRxiv - Immunology 2022Quote: ... Five million PBMC were suspended in 40 ml R10 supplemented with 10 ng/ml recombinant human IL-2 (R&D Systems, 202-IL-050) together with 10 million K562-mbIL21-41BBL feeder cells irradiated with 100 Gy ...
-
bioRxiv - Cancer Biology 2023Quote: ... TF1 cells were cultured in RPMI-1640 with 10% FBS and 1 ng/mL recombinant human granulocyte–macrophage colony-stimulating factor (rhGM-CSF, No. 215-GM, R&D Systems, Minneapolis, MN). 293T cells were cultured in DMEM media containing 10% FBS ...
-
bioRxiv - Bioengineering 2024Quote: ... were rinsed overnight in PBS at 4°C and then allowed to soak in droplets of either 100 μg/mL recombinant human FGF-10 (345-FG, R&D Systems; Minneapolis, MN) in PBS or 100 μg/mL RB (330000 ...
-
bioRxiv - Biochemistry 2020Quote: ... His-ubiquitin (R&D Systems; Cat. # U-530), HA-ubiquitin (R&D Systems ...
-
bioRxiv - Biochemistry 2020Quote: ... His-ubiquitin (R&D Systems; Cat. # U-530), HA-ubiquitin (R&D Systems ...
-
bioRxiv - Molecular Biology 2022Quote: ... His-HBP was purchased from R&D Systems. Purified His-HBP was incubated with beads bound with GST (control) ...
-
bioRxiv - Cell Biology 2023Quote: ... with 10% HI-FBS (R&D Systems S11150), 100x Pen/Strep (Gibco 15140-122) ...
-
bioRxiv - Immunology 2021Quote: ... Mouse recombinant CXCL13 (R&D Systems) treatment was initiated one day after the tumor inoculation and administered intraperitoneally at 1 µg/mouse every other day for five times ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant mouse VEGFA164 (R&D Systems), was used at 50 ng/ml for in vitro analyses ...
-
bioRxiv - Neuroscience 2022Quote: ... recombinant mouse Serpina3n (R&D Systems), at a concentration of 50 or 100 ng/ml ...
-
bioRxiv - Immunology 2022Quote: CD19 recombinant protein (R&D Systems) or anti-CD3 (Biolegend ...
-
bioRxiv - Immunology 2020Quote: ... recombinant IL-4 (R&D systems), and anti-CD40 (ThermoFisher ...
-
bioRxiv - Developmental Biology 2021Quote: ... recombinant mouse BMP7 (R&D Systems) at days 7-15 (range tested ...
-
bioRxiv - Immunology 2021Quote: ... or recombinant BAFF (R&D Systems) with or without recombinant mouse CD138 (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... Mouse recombinant VEGF164 (R&D Systems) was dissolved in sterile PBS and stored at −20°C ...
-
bioRxiv - Immunology 2023Quote: ... recombinant IL-27 (R&D systems) was added to the G4 media during dendritic cell differentiation at a concentration of 100 ng/ml ...
-
bioRxiv - Immunology 2023Quote: Recombinant mouse lactadherin (R&D Systems) and human APC (Cambridge ProteinWorks ...
-
bioRxiv - Immunology 2023Quote: Recombinant murine IFNγ (R&D Systems) was reconstituted in PBS containing 0.01% normal mouse serum ...
-
bioRxiv - Cell Biology 2024Quote: ... Recombinant mouse TNF (R&D Systems) was added to culture at the indicated concentrations.
-
bioRxiv - Cell Biology 2021Quote: ... or GST-tagged-Ubiquitin (R&D systems, U-540-01M). Incubation was performed overnight at 4°C in 500 µL 50 mM Tris.HCl ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... plates were incubated for 2 h at RT with 500 ng/mL (25 ng/well) recombinant biotinylated human ACE-2 (R&D Systems, Cat# BT933-020) diluted in PBSTBA ...
-
bioRxiv - Cancer Biology 2022Quote: ... freshly dissociated cells were plated at 10,000 cells per well in 100 μL of BTIC medium into a 96-well flat bottom plate in the presence or absence of 10 μg/mL recombinant human biglycan (R&D Systems, 2667-CM-050). We monitored cell growth using a real-time cell imaging system (IncuCyte live-cell ESSEN BioScience Inc) ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... and incubated with recombinant SARS-CoV-2 Spike protein receptor binding domain (RBD) fused to the human IgG1 Fc domain (R&D Systems 10499-CV-100) or control recombinant human IgG1 Fc protein (R&D Systems 10499-CV-100 ...
-
bioRxiv - Microbiology 2023Quote: ... Media was replaced with DMEM containing gentamicin and ciprofloxacin HCl alone or containing antibiotics and 10% NCS and/or 200 ng/mL Recombinant Human Insulin growth factor 1 (R&D Systems Cat#: 291-G1) for indicated minpost-treatment ...
-
bioRxiv - Physiology 2024Quote: ... minus 10 nM prostaglandin E2 and 2.5 μM Thiazovinin and with added human recombinant Wnt3A 50 ng/mL (R&D Systems, #5036-WN-010/CF), R-Spondin-1 250 ng/mL (Peprotech ...
-
bioRxiv - Microbiology 2024Quote: ... and differentiated into M1 or M2 macrophages by incubation for 7 days in the presence of 100 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage-colony stimulating factor (M-CSF) (R&D Systems, Minneapolis, MN, USA), respectively.
-
bioRxiv - Cell Biology 2024Quote: ... Mouse tibialis anterior muscles were injected with 50 uL solution of 50,000 human FAPs resuspended in 50% glycerol in PBS with either 29ng/ul concentration of recombinant DLK1 resuspended in PBS (R&D Systems, #1144-PR-025) or with control (identical volume of PBS ...
-
bioRxiv - Molecular Biology 2023Quote: MCF7 and T47D cell lines were perturbed using 5 ng/mL of recombinant human TGF-β (R&D Systems 240-B-002/CF, Minneapolis, MN) over the course of three days ...
-
bioRxiv - Molecular Biology 2023Quote: ... cells were seeded in 6 well plates and then mock-treated or treated with 5000 U/mL of human recombinant IFNβ (R&D systems, 8499-IF/CF) for 24 hours.
-
bioRxiv - Genetics 2023Quote: ... IMR90 fibroblasts at 70-80 % confluent were serum starved overnight and treated with 50ng/ml of recombinant human PDGF-DD (R&D system, 1159-SB-025) for 24h.
-
bioRxiv - Cancer Biology 2024Quote: ... spheres incubated under non adherent conditions for 5 days were challenged with the addition of 500 ng/ml human recombinant Netrin-1 (R&D Systems #6419-N1-025) for a period of 20 minutes before collection ...
-
bioRxiv - Systems Biology 2024Quote: ... TGF-β treated samples received the same medium with an additional 10 ng/ml of recombinant human TGF-β1 (R&D systems 240-B-010). Until the treatment started and for the 0 h treatments ...
-
bioRxiv - Cell Biology 2024Quote: ... HA1ER-derived clone F12 and subclones 1F8 and 1C9 were challenged with recombinant human TRAIL (rhTRAIL, 1μg/ml, R&D Systems, cat. 375-LT-010) for 4 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... and His-p53 was obtained from R&D system.
-
bioRxiv - Cancer Biology 2024Quote: ... HIS Tag APC-conjugated Antibody (R&D Systems, #IC050A); Human HVEM/TNFRSF14 polyclonal antibody (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... Media was then exchanged to DMEM containing 15 ng/mL recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF; R&D Systems # 215-GM-010/CF). PBMC Mϕ were allowed to differentiate for an additional 5 days and were returned to DMEM 10% FBS until stimulation.
-
bioRxiv - Cancer Biology 2020Quote: ... Cells were pre-treated for 1 day with vehicle control (0.1% BSA in 1X PBS) or 400 ng/ml human recombinant IL-1RA (R&D Systems, Minneapolis, MN; 280-RA/CF) 0 in the DMEM/10% FBE growth medium ...
-
bioRxiv - Neuroscience 2020Quote: ... while MABs differentiation into myotubes was initiated in the opposite compartments using MAB differentiation medium containing 2% horse serum (Cat N° 16050122) and 1% sodium pyruvate in DMEM/F12 supplemented with 0.01 μg/ml recombinant human agrin protein (R&D Systems, Cat N° 6624-AG-050). At day 21 ...
-
bioRxiv - Biochemistry 2024Quote: ... Gi-bound complex sample) or mixed with 0.5 mg/mL CXCL12 (Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1 alpha, R&D Systems Catalog #: 350-NS-050/CF), or 1 mM AMD3100 (AMD 3100 octahydrochloride ...
-
bioRxiv - Neuroscience 2024Quote: ... explants were treated with 10 ng/mL human recombinant IL- 6 and soluble IL-6 receptor (IL-6-sIL-6R) (1:1; R&D Systems 206-IL-050; I5771) for 20 mins ...
-
bioRxiv - Cell Biology 2024Quote: ... heat shock treated cells were lysed with 1× cell lysis buffer without 20 mM NEM and then incubated with 220 nM recombinant Human Sentrin-specific protease 1 (SENP1) catalytic domain (R&D Systems, Catalog no. E-700) at 37 °C for 20 min before immunoblotting analysis.
-
bioRxiv - Genomics 2024Quote: ... 3 units/mL EPO (Amgen, EPOGEN NDC 55513-144-01), 200 μg/mL holo-transferrin (Millipore Sigma, T0665, 10 ng/mL recombinant human SCF (R&D systems, 255-SC/CF), and 1 ng/mL recombinant human interleukin IL-3 (R&D systems ...
-
bioRxiv - Immunology 2024Quote: ... cells were maintained in resting conditions by culturing in simple R10 or R10 supplemented with 10 ng/mL of recombinant human interleukin-7 (IL-7, R&D Systems, cat. BT-007-010) for one week.